| Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial PM Voorhees, JL Kaufman, J Laubach, DW Sborov, B Reeves, ... Blood, The Journal of the American Society of Hematology 136 (8), 936-945, 2020 | 598 | 2020 |
| Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study SG Mohile, MR Mohamed, H Xu, E Culakova, KP Loh, A Magnuson, ... The Lancet 398 (10314), 1894-1904, 2021 | 305 | 2021 |
| Older adult participation in cancer clinical trials: a systematic review of barriers and interventions MS Sedrak, RA Freedman, HJ Cohen, HB Muss, A Jatoi, HD Klepin, ... CA: a cancer journal for clinicians 71 (1), 78-92, 2021 | 292 | 2021 |
| Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline J Mikhael, N Ismaila, MC Cheung, C Costello, MV Dhodapkar, S Kumar, ... Journal of Clinical Oncology 37 (14), 1228-1263, 2019 | 262 | 2019 |
| Systematic review of falls in older adults with cancer TM Wildes, P Dua, SA Fowler, JP Miller, CR Carpenter, MS Avidan, ... Journal of geriatric oncology 6 (1), 70-83, 2015 | 174 | 2015 |
| Predicting geriatric falls following an episode of emergency department care: a systematic review CR Carpenter, MS Avidan, T Wildes, S Stark, SA Fowler, AX Lo Academic Emergency Medicine 21 (10), 1069-1082, 2014 | 149 | 2014 |
| Senior adult oncology, version 2.2014 A Hurria, T Wildes, SL Blair, IS Browner, HJ Cohen, M Deshazo, E Dotan, ... Journal of the National Comprehensive Cancer Network 12 (1), 82-126, 2014 | 147 | 2014 |
| Time to stop saying geriatric assessment is too time-consuming. S Rostoft, TP Wildes Journal of Clinical Oncology, 2871-2874, 2017 | 141 | 2017 |
| Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score KM Sanfilippo, S Luo, TF Wang, M Fiala, M Schoen, TM Wildes, J Mikhael, ... American journal of hematology 94 (11), 1176-1184, 2019 | 138 | 2019 |
| Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer TM Wildes, AP Ruwe, C Fournier, F Gao, KR Carson, JF Piccirillo, B Tan, ... Journal of geriatric oncology 4 (3), 227-234, 2013 | 134 | 2013 |
| Senior adult oncology A Hurria, IS Browner, HJ Cohen, CS Denlinger, M DeShazo, M Extermann, ... Journal of the National Comprehensive Cancer Network 10 (2), 162-209, 2012 | 130 | 2012 |
| NCCN guidelines insights: older adult oncology, version 2.2016 N VanderWalde, R Jagsi, E Dotan, J Baumgartner, IS Browner, P Burhenn, ... Journal of the National Comprehensive Cancer Network 14 (11), 1357-1370, 2016 | 95 | 2016 |
| Racial disparities in treatment use for multiple myeloma MA Fiala, TM Wildes Cancer 123 (9), 1590-1596, 2017 | 93 | 2017 |
| Effect of intensive chemotherapy on physical, cognitive, and emotional health of older adults with acute myeloid leukemia HD Klepin, JA Tooze, TS Pardee, LR Ellis, D Berenzon, SL Mihalko, ... Journal of the American Geriatrics Society 64 (10), 1988-1995, 2016 | 92 | 2016 |
| Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV negative head and neck squamous cell carcinoma (HNSCC). R Uppaluri, P Zolkind, T Lin, B Nussenbaum, RS Jackson, J Rich, ... Journal of Clinical Oncology 35 (15_suppl), 6012-6012, 2017 | 90 | 2017 |
| Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell … L Michel, J Ley, TM Wildes, A Schaffer, A Robinson, SE Chun, W Lee, ... Oral oncology 58, 41-48, 2016 | 90 | 2016 |
| Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma TM Wildes, KM Augustin, D Sempek, QJ Zhang, R Vij, JF Dipersio, ... Biology of Blood and Marrow Transplantation 14 (7), 840-846, 2008 | 90 | 2008 |
| Multiple myeloma in the older adult: better prospects, more challenges TM Wildes, A Rosko, SA Tuchman Journal of clinical oncology 32 (24), 2531, 2014 | 85 | 2014 |
| Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life CR Spencer, HA Gay, BH Haughey, B Nussenbaum, DR Adkins, ... Cancer 120 (24), 3994-4002, 2014 | 79 | 2014 |
| Development and validation of a risk tool for predicting severe toxicity in older adults receiving chemotherapy for early-stage breast cancer A Magnuson, MS Sedrak, CP Gross, WP Tew, HD Klepin, TM Wildes, ... Journal of Clinical Oncology 39 (6), 608, 2021 | 78 | 2021 |
